Nevan Elam, J.D. CEO and co-founder Rezolute, Inc. talks about their work developing therapeutics for congenital hyperinsulinism, a rare pediatric disease and for diabetic macular edema, a vision-related complication of diabetes. With a background of working with technology businesses, Nevan reflects on lessons learned and differences in drivers of innovation in the computer and biotech worlds.
@rezolutebio
#RareDisease #PediatricDisease #DME #DiabeticMacularEdema #Diabetes #hyperinsulinism
RezoluteBio.com
Download the transcript here
Empowered Patient Podcast